Reaction
Product Deposit reporting signals
As of the last recalculation, Product Deposit appears in 1,516 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is TESTOSTERONE CYPIONATE (PRR 620.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Testosterone Cypionate | 319 | 620.7 | 643.8 |
| Testosterone | 147 | 95.5 | 96.1 |
| Epoprostenol | 28 | 29.9 | 30.0 |
| Octreotide Acetate | 44 | 20.3 | 20.3 |
| Brinzolamide | 11 | 17.5 | 17.5 |
| Dorzolamide Hydrochloride And Timolol Maleate | 9 | 15.7 | 15.7 |
| Somatropin | 68 | 13.3 | 13.3 |
| Timolol Maleate | 9 | 12.5 | 12.6 |
| Meropenem | 22 | 9.5 | 9.5 |
| Posaconazole | 11 | 9.4 | 9.4 |
| Prednisolone Acetate | 7 | 9.3 | 9.3 |
| Brimonidine Tartrate | 12 | 9.3 | 9.3 |
| Lanreotide Acetate | 4 | 7.0 | 7.0 |
| Ruxolitinib | 35 | 6.8 | 6.8 |
| Travoprost | 4 | 6.4 | 6.4 |
| Lifitegrast | 5 | 4.2 | 4.2 |